The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysisTomislav Meštrović, Alexander G. Mathioudakis, Mohsen Naghavi et al.|The Lancet Public Health|2022Cited by 350
Amyloid-beta and tau protein beyond Alzheimer’s diseaseMorteza Abyadeh, Mehdi Mirzaei, Vivek Gupta et al.|Neural Regeneration Research|2023Cited by 98
Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer’s DiseaseMorteza Abyadeh, Mehdi Mirzaei, Vivek Gupta et al.|Aging and Disease|2021Cited by 62
Mitochondrial dysfunction in Alzheimer’s disease - a proteomics perspectiveMorteza Abyadeh, Mehdi Mirzaei, Vivek Gupta et al.|Expert Review of Proteomics|2021Cited by 49
Key Genes and Biochemical Networks in Various Brain Regions Affected in Alzheimer’s DiseaseMorteza Abyadeh, Mehdi Mirzaei, Nahid Tofigh et al.|Cells|2022Cited by 36